Company
BioGend Therapeutics Co. Ltd
Headquarters: Taipei City, Taiwan
Market Cap
TW$4.70 Billion
TWD as of Jan. 1, 2024
US$153.2 Million
BioGend Therapeutics Co. Ltd Categories
Taiwan Healthcare BiotechnologyTaiwan Healthcare Taiwan Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
BioGend Therapeutics Co., Ltd. develops regenerative bio-orthopaedic products. The company is developing BiG-001 and BiG-006, an osteoinductive bone graft substitute; and BiG-009, an autologous cartilage repair system. BioGend Therapeutics Co., Ltd. was founded in 2016 and is based in Taipei, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
BioGend Therapeutics Co. Ltd has the following listings and related stock indices.
Stock: TWSE: 6733 wb_incandescent